Sanford Health News: Latest Updates on Clinical Trials and Research
Sanford Health is a non-profit health system in the United States, particularly located in the Dakotas. Its mission is to improve the human condition through exceptional care, innovation, and discovery. As part of its vision, Sanford Health is committed to clinical trials and research to discover new treatments, cures, and therapies for various illnesses and diseases.
In this blog article, we will explore the latest updates on clinical trials and research by Sanford Health. We will examine the brightest minds and dedicated workers at Sanford Health who are revolutionizing healthcare through their clinical trials and research.
Sanford Health Enrolls First Patient in its Clinical Trial for Device to Treat Residual Limb Pain
Sanford Health just enrolled its first patient in a clinical trial on a device to treat residual limb pain. This clinical trial aims to study the effectiveness and safety of a first-of-its-kind device called “NEuroadaptive CLosing-In WEaring” (NECLIME).
NECLIME is a prosthetic socket liner that uses artificial intelligence to adapt to the patient’s individual walking patterns and unique gait, providing targeted pressure relief to residual limb pain. It is an innovative approach to residual limb pain management that is expected to improve the quality of life of patients with lower-limb amputations.
Sanford Health’s Research on the Long-Term Effects of COVID-19
Sanford Health’s researchers are also studying the long-term effects of COVID-19 on patients who have recovered from the illness. The study follows the progress of recovered COVID-19 patients for a year after their initial diagnosis or admission to the hospital.
Researchers at Sanford Health will examine the patients’ lung function, neurological and cognitive function, as well as the emotional and psychological effects of prolonged isolation, hospitalization, and quarantine. The study aims to provide a better understanding of the long-term effects of COVID-19 on patients and guide efforts towards better post-COVID-19 care.
Sanford Health’s Clinical Trial on a COVID-19 Treatment
Sanford Health is conducting one of the leading clinical trials for a potential COVID-19 treatment called monoclonal antibodies. The clinical trial involves giving patients a single infusion of monoclonal antibodies to counteract the COVID-19 virus.
The clinical trial is a collaboration between Sanford Health and the pharmaceutical company Eli Lilly and Company. The trial has shown promising results, with early data suggesting that these antibodies could significantly reduce the need for hospitalization in patients with mild to moderate COVID-19 symptoms.
The Bottom Line
Sanford Health is making great strides in clinical trials and research, with dedicated researchers and workers committed to finding new treatments and cures for various illnesses and diseases. From studying the long-term effects of COVID-19 to developing innovative prosthetic devices to treat residual limb pain, Sanford Health is on the forefront of healthcare innovation. By continuing to invest in clinical trials and research, Sanford Health is bringing new hope to patients and improving the human condition.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)
Speech tips:
Please note that any statements involving politics will not be approved.